SK Biopharmaceuticals Co Ltd

Common Name
SK Biopharmaceuticals
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
246
Ticker
326030
Exchange
KOREA EXCHANGE
Description
Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with ...

Disclosures of SK Biopharmaceuticals

Explore SK Biopharmaceuticals's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from SK Biopharmaceuticals's official channels and fully traceable to its official company sources.

The table below lists all of SK Biopharmaceuticals's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Sustainability Report2025
Sustainability Report2024
Financial Report2024
Sustainability Report2023
Financial Report2023
Financial Report2022
Sustainability Report2021
Financial Report2021
Financial Report2020
Sustainability Report2020
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?